Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    WS07 - LATAM Workshop

    • 15:00 - 16:30
    • 8/06/2022
    • Location: Lehar 2
    • Not for CME Credit
    • Type: Workshop
    • Track: N/A
    • +

      WS07.06 - Real-world Evidence of Durvalumab for Stage III NSCLC: Survival Outcomes and Patterns of Care Post-progression

      15:32 - 15:42  |  Presenter: Pedro Aguiar Jr

      • Abstract

      Loading...

  • +

    EP04.01 - Global Health, Health Services Research, and Health Economics - Cost Issues

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Global Health, Health Services Research, and Health Economics - Cost Issues
    • +

      EP04.01-022 - Real-world Evidence of Durvalumab for Stage III NSCLC: Survival Outcomes and Patterns of Care Post-progression

      Presenter: Pedro Aguiar Jr

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-042 - EGFR-TKI +/- Antiangiogenics for EGFR-mutated Advanced NSCLC

      Presenter: Laercio Lopes DaSilva

      • Abstract

      Loading...